Gregory T. Carter, M.D.
Dr. Carter is a UW professor of rehabilitation medicine. He co-directs the Muscular Dystrophy Association/Amyotrophic Lateral Sclerosis Center. He is a founding member of the neuromuscular medicine subspecialty board of the American Board of Neurology and Psychiatry. He also serves on the editorial boards of the journals Muscle and Nerve, the Journal of Clinical Neuromuscular Disease and the American Journal of Hospice and Palliative Medicine.
His goal is to take care of the whole person, not simply the disease symptoms. This might include making lifestyle and nutritional recommendations as well as rehabilitation modalities and medicines. He aims to improve the quality of life for those with disabilities.
He sees patients with all forms of neuromuscular disorders. He has an interest in the management of neuropathic pain in the population of patients with hereditary neuropathies.
His clinical practice is focused on the rehabilitation and palliative care of people with severe neuromuscular disease, particularly amyotrophic lateral sclerosis (ALS), and Duchenne muscular dystrophy (DMD), with the goal of trying to improve the quality of life and lessening the burden of disease for these patients. Dr. Carter is also an electrodiagnostician with special expertise in diagnoses of hereditary neuromuscular disorders, including peripheral neuropathies, muscular dystrophies, and motor neuron diseases.
English
Neuromuscular Diseases, Rehabilitation Medicine
Neuromuscular disease (NMD) and electrodiagnosis (Edx).
The relationship between pain, physical disability, and quality of life in neuromuscular disease (NMD) with the goal of developing better treatment protocols. He was among the first investigators to identify the effectiveness of marijuana in treating ALS, spawning a new field of research.
His research has also helped document the degree of pain that people with NMD experience. Many of these disorders had previously been described in medical texts as “painless." His pre-clinical research involves characterizing the electrophysiology of genetically corrected animal models of human NMD. His work has demonstrated how electromyography may be used to longitudinally assess the effectiveness of genetic manipulation in mice with NMD. He currently has co-authored more than 100 peer-reviewed journal publications, six book chapters and dozens of editorials, letters and reviews.
Loyola U. Stritch School Medicine, Medical education, 1986
Univ. of Calif. Davis Medical Center, Internship
Univ. of Calif. Davis Medical Center, Residency
Univ. of Calif. Davis Medical Center, Fellowship |
| Certification Board Name | Specialty | Year Certified |
| American Board of Physical Medicine & Rehab | Physical Medicine & Rehabilitation | 1991 |
| American Board of Psychiatry & Neurology | Neuromuscular Disease | 2006 |
| Year | Name |
| 2007 | Listing in Castle Connolly Medical Ltd “America’s Top Doctors” |
| 2002 | Excellence in Clinical Care Award, Muscular Dystrophy Association |
| 2001 | Listing in "Best Doctors in America" 2001-2008 |
| 1998 | Excellence in Research Writing Award, Association of Academic Physiatrists |
| 1994 | Best Research Paper Published by a Physiatrist Award from the American Academy of Physical Medicine and Rehabilitation |
Searching for Publications, Please Wait . . .
|